KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Non Operating Income (2018 - 2025)

Vir Biotechnology's Non Operating Income history spans 8 years, with the latest figure at $4.9 million for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 109.03% to $4.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.5 million, a 172.04% increase, with the full-year FY2025 number at $41.6 million, up 1971.14% from a year prior.
  • Non Operating Income hit $4.9 million in Q4 2025 for Vir Biotechnology, down from $10.5 million in the prior quarter.
  • Over the last five years, Non Operating Income for VIR hit a ceiling of $27.0 million in Q3 2022 and a floor of -$91.9 million in Q1 2022.
  • Historically, Non Operating Income has averaged -$2.5 million across 5 years, with a median of $458500.0 in 2022.
  • The widest YoY moves for Non Operating Income: up 42128.12% in 2022, down 374000.0% in 2022.
  • Tracing VIR's Non Operating Income over 5 years: stood at -$7000.0 in 2021, then tumbled by 374000.0% to -$26.2 million in 2022, then surged by 169.73% to $18.3 million in 2023, then crashed by 394.68% to -$53.8 million in 2024, then soared by 109.03% to $4.9 million in 2025.
  • Business Quant data shows Non Operating Income for VIR at $4.9 million in Q4 2025, $10.5 million in Q3 2025, and $226000.0 in Q2 2025.